Infectious Disease Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
The infectious disease diagnostics market is expected to grow from US$ 38.366 billion in 2022 to US$ 59.954 billion by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030. The growing incidence of infectious diseases across the world and rising application of diagnostics in veterinary infectious diseases bolster the infectious disease diagnostics market size. However, an inadequate reimbursement scenario hinders the infectious disease diagnostics market growth.
Rising Incidence of Infectious Diseases Drive Infectious Disease Diagnostics Market Growth
Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0–14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.
According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).
The report segments the infectious disease diagnostics market as follows:
The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Product-Based Insights
The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022–2030.
Regional-Based Insights
Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022–2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players.
Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.
A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the World Health Organization (WHO), the US Census Bureau, The Journal for Infectious Diseases, International Journal of Infectious Diseases, and CDC, among others.
Rising Incidence of Infectious Diseases Drive Infectious Disease Diagnostics Market Growth
Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0–14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.
According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).
The report segments the infectious disease diagnostics market as follows:
The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Product-Based Insights
The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022–2030.
Regional-Based Insights
Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022–2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players.
Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.
A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the World Health Organization (WHO), the US Census Bureau, The Journal for Infectious Diseases, International Journal of Infectious Diseases, and CDC, among others.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance.
1.2 Market Segmentation.
2. EXECUTIVE SUMMARY
2.1 Key Insights.
2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage.
3.2 Secondary Research.
3.3 Primary Research.
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview.
4.2 PEST Analysis.
4.2.1 Global PEST Analysis.
5. INFECTIOUS DISEASE DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Market Drivers:
5.1.1 Rising Incidence of Infectious Diseases.
5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease.
5.2 Market Restraints.
5.2.1 Inadequate Reimbursement Scenario.
5.3 Market Opportunities.
5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics.
5.4 Future Trends.
5.4.1 Rising Number of Product Approvals and Launches.
5.5 Impact Analysis:
6. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030.
7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY PRODUCT
7.1 Overview.
7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Kits & Reagents.
7.3.1 Overview.
7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments.
7.4.1 Overview.
7.4.2 Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services.
7.5.1 Overview.
7.5.2 Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview.
8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
8.3 Biosensor-based.
8.3.1 Overview.
8.3.2 Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Immunodiagnostics.
8.4.1 Overview.
8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
8.5 Molecular-Based Diagnostic Techniques.
8.5.1 Overview.
8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
8.6 Clinical Biology.
8.6.1 Overview.
8.6.2 Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others.
8.7.1 Overview.
8.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION TYPE
9.1 Overview.
9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
9.3 Point-of-Care Testing.
9.3.1 Overview.
9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratory Testing.
9.4.1 Overview.
9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TESTING TYPE
10.1 Overview.
10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
10.3 Human Testing.
10.3.1 Overview.
10.3.2 Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
10.4 Veterinary Testing.
10.4.1 Overview.
10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
11.1 Overview.
11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
11.3 Diagnostic Laboratories.
11.3.1 Overview.
11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals and Clinics.
11.4.1 Overview.
11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5 Research Institutes.
11.5.1 Overview.
11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.6 Homecare Settings.
11.6.1 Overview.
11.6.2 Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.7 Others.
11.7.1 Overview.
11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
12. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GEOGRAPHICAL ANALYSIS
12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030.
12.1.1 Overview.
12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.1.8 North America Infectious Disease Diagnostics Market, by Country.
12.1.8.1 US.
12.1.8.1.1 Overview
12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.1.8.2 Canada.
12.1.8.2.1 Overview
12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.1.8.3 Mexico.
12.1.8.3.1 Overview
12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.2.1 Overview.
12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8 Europe Infectious Disease Diagnostics Market, by Country.
12.2.8.1 UK
12.2.8.1.1 Overview
12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.2 Germany.
12.2.8.2.1 Overview
12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.3 France.
12.2.8.3.1 Overview
12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.4 Italy.
12.2.8.4.1 Overview
12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.5 Spain.
12.2.8.5.1 Overview
12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.6 Rest of Europe.
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.3.1 Overview.
12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country.
12.3.8.1 China.
12.3.8.1.1 Overview
12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.2 Japan.
12.3.8.2.1 Overview
12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.3 India.
12.3.8.3.1 Overview
12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.4 South Korea.
12.3.8.4.1 Overview
12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.5 Australia.
12.3.8.5.1 Overview
12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.6 Rest of Asia Pacific.
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.4.1 Overview.
12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country.
12.4.7.2 Saudi Arabia.
12.4.7.2.1 Overview
12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.3 South Africa.
12.4.7.3.1 Overview
12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.4 UAE.
12.4.7.4.1 Overview
12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.5 Rest of Middle East & Africa.
12.4.7.5.1 Overview
12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.5.1 Overview.
12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country.
12.5.8.1 Brazil
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End Use
1.1 The Insight Partners Research Report Guidance.
1.2 Market Segmentation.
2. EXECUTIVE SUMMARY
2.1 Key Insights.
2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage.
3.2 Secondary Research.
3.3 Primary Research.
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview.
4.2 PEST Analysis.
4.2.1 Global PEST Analysis.
5. INFECTIOUS DISEASE DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Market Drivers:
5.1.1 Rising Incidence of Infectious Diseases.
5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease.
5.2 Market Restraints.
5.2.1 Inadequate Reimbursement Scenario.
5.3 Market Opportunities.
5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics.
5.4 Future Trends.
5.4.1 Rising Number of Product Approvals and Launches.
5.5 Impact Analysis:
6. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030.
7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY PRODUCT
7.1 Overview.
7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Kits & Reagents.
7.3.1 Overview.
7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments.
7.4.1 Overview.
7.4.2 Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services.
7.5.1 Overview.
7.5.2 Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview.
8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
8.3 Biosensor-based.
8.3.1 Overview.
8.3.2 Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Immunodiagnostics.
8.4.1 Overview.
8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
8.5 Molecular-Based Diagnostic Techniques.
8.5.1 Overview.
8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
8.6 Clinical Biology.
8.6.1 Overview.
8.6.2 Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others.
8.7.1 Overview.
8.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION TYPE
9.1 Overview.
9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
9.3 Point-of-Care Testing.
9.3.1 Overview.
9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratory Testing.
9.4.1 Overview.
9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TESTING TYPE
10.1 Overview.
10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
10.3 Human Testing.
10.3.1 Overview.
10.3.2 Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
10.4 Veterinary Testing.
10.4.1 Overview.
10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
11.1 Overview.
11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
11.3 Diagnostic Laboratories.
11.3.1 Overview.
11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals and Clinics.
11.4.1 Overview.
11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5 Research Institutes.
11.5.1 Overview.
11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.6 Homecare Settings.
11.6.1 Overview.
11.6.2 Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.7 Others.
11.7.1 Overview.
11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
12. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GEOGRAPHICAL ANALYSIS
12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030.
12.1.1 Overview.
12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.1.8 North America Infectious Disease Diagnostics Market, by Country.
12.1.8.1 US.
12.1.8.1.1 Overview
12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.1.8.2 Canada.
12.1.8.2.1 Overview
12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.1.8.3 Mexico.
12.1.8.3.1 Overview
12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.2.1 Overview.
12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8 Europe Infectious Disease Diagnostics Market, by Country.
12.2.8.1 UK
12.2.8.1.1 Overview
12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.2 Germany.
12.2.8.2.1 Overview
12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.3 France.
12.2.8.3.1 Overview
12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.4 Italy.
12.2.8.4.1 Overview
12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.5 Spain.
12.2.8.5.1 Overview
12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.2.8.6 Rest of Europe.
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.3.1 Overview.
12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country.
12.3.8.1 China.
12.3.8.1.1 Overview
12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.2 Japan.
12.3.8.2.1 Overview
12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.3 India.
12.3.8.3.1 Overview
12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.4 South Korea.
12.3.8.4.1 Overview
12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.5 Australia.
12.3.8.5.1 Overview
12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.3.8.6 Rest of Asia Pacific.
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.4.1 Overview.
12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country.
12.4.7.2 Saudi Arabia.
12.4.7.2.1 Overview
12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.3 South Africa.
12.4.7.3.1 Overview
12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.4 UAE.
12.4.7.4.1 Overview
12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.4.7.5 Rest of Middle East & Africa.
12.4.7.5.1 Overview
12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030.
12.5.1 Overview.
12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million)
12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country.
12.5.8.1 Brazil
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million)
12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million)
12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million)
12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million)
12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million)
12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million)
12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million)
12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End Use
